Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03656224 · ClinicalTrials.gov registry record
Survey of Post-Acute Inpatient Rehabilitation Safety Concerns in Participants With Cancer
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 261
- Enrollment target
NCT03656224: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT03656224 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 261 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03656224 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 261 participants
- Enrollment target
Study Summary
This trial studies a survey of post-acute inpatient rehabilitation safety concerns in participants with cancer. Collecting patients' feedback via surveys may help doctors to learn more about the safety concerns that patients have when they are discharged from the acute inpatient cancer rehabilitation unit.
Primary Outcome
Will be assessed by Patient Continuity of Care Checklist and Perceptions Regarding Safety after Rehabilitation. At the end of study, patients' demographics and clinical characteristics will be summarized for all the patients who participated in the study by standard descriptive statistics such as mean, standard deviation, median, and range for continuous variables and frequency and proportion for categorical variables. The association between these characteristics and feeling safe will be evalua
Interventions
- OTHER Survey Administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 261 participants |
| Start Date | 2018-08-29 |
| Est. Completion | 2021-08-16 |
What the finished NCT03656224 record still lists
NCT03656224 is an observational study that tracks outcomes without assigning an intervention. The registered 261 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Survey Administration is the first listed.
NCT03656224 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03656224 about?
NCT03656224 is a clinical study titled "Survey of Post-Acute Inpatient Rehabilitation Safety Concerns in Participants With Cancer". This trial studies a survey of post-acute inpatient rehabilitation safety concerns in participants with cancer. Collecting patients' feedback via surveys may help doctors to learn more about the safety concerns that patients have when they are discharged from the acute inpatient cancer rehabilitatio...
What is the current status of trial NCT03656224?
This trial is currently completed. The enrollment target is 261 participants. The study started on 2018-08-29. Estimated completion is 2021-08-16.
What interventions are being tested in trial NCT03656224?
The interventions under investigation include: Survey Administration (OTHER).
Who is sponsoring clinical trial NCT03656224?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05124912 · 261 participants · NA
REMASTer: REcurrent Brain Metastases After SRS Trial
- NCT06559891 · 261 participants · NA
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
- NCT03713268 · 262 participants
Intraoperative OCT Guidance of Intraocular Surgery II
- NCT06074380 · 262 participants · Phase 4
Non Inferiority Trial Investigating Surfactants Administered Via MIST
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI